M&A
Most Read
STAT Plus: Republican lawmakers want FTC to probe PBM mergers over drug pricing concerns
STAT Plus: Pharmalittle: Sanofi warns Canada over industry treatment; Pfizer got a big boost from the new tax law
STAT Plus: Pharmalittle: Pfizer paid its CEO how much? Glaxo says Brexit will not be cheap
STAT Plus: Pharmalittle: Bristol gets a win for its cancer drug; Sanofi refuses to refund Philippines for dengue vaccine
STAT Plus: The biotech M&A spotlight shifts to Biogen, with some clear candidates to acquire
STAT Plus: Sanofi makes a steep bid for a hemophilia business, but did it make a good case?